Showing results (101-110 of 673) with videos related to
Sort By:
Pageof 68
HIV Clinical Trials|November 9, 2012
Effect of darunavir on lipid profile in HIV-infected patientsEdgar Turner Overton, Eduardo Arathoon, Ezio Baraldi, et al.HIV Clinical Trials|March 18, 2015
The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of ageJaime H Vera, Akil Jackson, Laura Dickinson, et al.HIV Clinical Trials|March 18, 2015
Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain: The TRIP studyEnric Pedrol, Ana M Caro-Murillo, Manuel A Castaño, et al.HIV Clinical Trials|August 28, 2007
Changes in facial fat in HIV-related lipoatrophy, wasting, and weight gain measured by magnetic resonance imagingNicholas I Paton, Yong Yang, Naing Oo Tha, et al.HIV Clinical Trials|August 30, 2008
Cost-effectiveness of tipranavir in treatment-experienced HIV patients in the United StatesKit N Simpson, Graeme Roberts, Charles B Hicks, et al.HIV Clinical Trials|August 30, 2008
Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormoneDerek C Macallan, Christine Baldwin, Sundihya Mandalia, et al.HIV Clinical Trials|August 30, 2008
AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristicsMarlene Smurzynski, Ann C Collier, Susan L Koletar, et al.HIV Clinical Trials|August 30, 2008
The significance of low-level plasma HIV viral load on COBAS TaqMan HIV-1 assays for patients with undetectable plasma viral load on COBAS Amplicor monitor version 1.5Kaveh ManaviHIV Clinical Trials|October 25, 2007
An estimate of the proportion of symptoms reported in self-administered questionnaires that are captured as adverse drug events in an observational databaseJanet Raboud, Maia Lesosky, Sherine Sterling, et al.HIV Clinical Trials|November 4, 2008
Statements from the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), Toulon, France, May 28-30, 2008Richard Haubrich, Vincent Soriano, Alain LafeuilladePageof 68